Atriomx Health

Atriomx is a private U.S. health technology and medical device company developing non-invasive solutions to detect and characterize the disease mechanisms underlying atrial fibrillation and other arrhythmias. The company combines clinical hardware, software, and proprietary algorithms to generate deep electrophysiology insights intended to guide treatment selection before patients undergo invasive procedures. Atriomx appears focused on cardiac diagnostics rather than therapeutics, with its core value proposition centered on improving arrhythmia understanding and patient stratification. Publicly available information indicates the company raised an early-stage financing round to support initial development and clinical study of its platform.